GeminIQ Website Logo

Viewing BDSX free

Subscribe for full history, 50+ metrics, screener, watchlist...

BIODESIX INC

BDSX

Companies in Services-Medical Laboratories

BIODESIX INC (BDSX) — SEC Financial Statements & Analysis

BIODESIX INC (BDSX) files its annual 10-K and quarterly 10-Q reports directly with the SEC. The financial data below is sourced as-filed from EDGAR — balance sheet, income statement, and cash flow as reported, without normalization or third-party adjustments.

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Assets
Cash And Cash Equivalents At Carrying Value
261917211826314211262017
Assets Current
Accounts Receivable Net Current
1091378981010864
Assets Current
413333323039445828402925
Other Assets Current
644445557634
Property Plant And Equipment Net
242525262728292829282519
Intangible Assets Net Excluding Goodwill
344556677889
Assets Noncurrent
Assets Noncurrent
545555555758595859595852
Operating Lease Right Of Use Asset
333222222222
Goodwill
151515151515151515151515
Other Assets Noncurrent
888777776777
Assets
95878988869710311687998778
Liabilities And Stockhold…
Accounts Payable Current
434332323334
Accrued Liabilities Current
8111010710988877
Contract With Customer Liability Current
013111100011
Liabilities Current
Liabilities Current
141718151314131831333328
Operating Lease Liability Current
111111100012
Business Combination Contingent Consideration Liab…
-------619221915
Notes Payable To Bank Current
000000000000
Other Liabilities Current
111111100020
Long Term Notes Payable
464747473736363636352525
Operating Lease Liability Noncurrent
242424242425252525252519
Liabilities Noncurrent
Liabilities Noncurrent
717372716262626261615657
Business Combination Contingent Consideration Liab…
----------512
Other Liabilities Noncurrent
111111111111
Liabilities
869090877576758093958885
Stockholders Equity
Common Stock Value
000000000000
Stockholders Equity
9-2-2111212836-65-1-7
Additional Paid In Capital
515495492486485483482480428424409392
Retained Earnings Accumulated Deficit
-506-498-494-485-474-462-454-444-433-420-410-399
Liabilities And Stockholders Equity
95878988869710311687998778
Allowance For Doubtful Accounts Receivable
000000000000
Preferred Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Preferred Stock Shares Authorized
555555555555
Preferred Stock Shares Issued
000000000000
Preferred Stock Shares Outstanding
000000000000
Common Stock Par Or Stated Value Per Share
0.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.0010.001
Common Stock Shares Authorized
200200200200200200200200200200200200
Common Stock Shares Issued
1088770775544
Shares Outstanding
1088777775554
Stockholders Equity Note Stock Split Conversion Ra…
--0---------

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
202644.81%107.10%----------
2025-15.60%-24.23%1.11%-4.47%-13.31%-24.72%30.60%7.57%85.17%4.61%-7.59%-0.35%
2024-7.74%-1.29%10.97%23.27%7.55%3.14%-1.54%20.77%-11.54%-6.03%-24.40%-51.89%
2023-21.05%-28.07%-37.43%-0.65%7.14%-9.74%0.68%24.32%33.11%-12.66%-20.89%-0.32%

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data and 50+ calculated metrics

Performance and Valuation Metrics

Metrics
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
2023-06-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Data beyond 3 years is for subscribers only.

Unlock 17+ years of financial data

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
2.82
1.86
1.84
2.14
2.22
2.76
3.40
3.28
0.91
1.19
0.88
0.90
Quick Ratio
2.82
1.86
1.84
2.14
2.22
2.76
3.40
3.28
0.91
1.19
0.88
0.90
Working Capital
26.42M
15.08M
15.25M
17.29M
16.31M
25.17M
31.05M
40.03M
-2.75M
6.27M
-3.76M
-2.71M
Leverage & Debt
Debt to Equity
9.36
-36.49
-52.52
76.10
6.80
3.66
2.69
2.19
-16.85
20.64
-61.02
-12.10
Interest Coverage TTM
-3.11
-3.61
-4.39
-4.62
-4.40
-4.18
-3.93
-3.63
-3.72
-4.34
-4.96
-4.98
Debt Ratio
0.90
1.03
1.02
0.99
0.87
0.79
0.73
0.69
1.06
0.95
1.02
1.09
Efficiency & Turnover
Asset Turnover TTM
1.06
0.96
0.84
0.75
0.86
0.73
0.69
0.63
0.65
0.51
0.59
0.54
Days Sales Outstanding TTM
32.55
36.37
47.14
41.91
42.97
41.66
38.45
42.69
49.22
47.38
42.39
41.95
Receivables Turnover TTM
11.21
10.03
7.74
8.71
8.49
8.76
9.49
8.55
7.42
7.70
8.61
8.70
Per Share Metrics
Diluted EPS TTM
-3.31
-4.67
-5.27
-5.60
-5.54
-6.64
-5.99
-5.95
-8.23
-10.80
-13.51
-14.31
Free Cash Flow Per Share TTM
-2.60
-3.12
-3.89
-4.25
-6.17
-8.02
-8.50
-8.15
-8.04
-9.48
-9.47
-9.92
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
-
-
-
-
-
-
-
115.07%
117.64%
119.43%
122.16%
125.00%
Operating Profit Margin TTM
-25.95%
-31.50%
-40.61%
-44.54%
-43.80%
-48.37%
-52.96%
-54.68%
-65.62%
-84.22%
-109.85%
-124.39%
Net Profit Margin TTM
-33.26%
-39.85%
-49.31%
-53.66%
-54.28%
-60.19%
-66.84%
-73.08%
-85.80%
-106.23%
-143.88%
-158.72%
Growth Metrics
Net Revenue Growth (1Y)
29.05%
24.08%
22.29%
25.70%
35.76%
45.30%
48.92%
46.25%
34.70%
28.46%
22.88%
33.24%
Net Income Growth (1Y)
-20.93%
-17.86%
-9.77%
-7.71%
-14.11%
-17.67%
-30.82%
-32.66%
-31.37%
-20.32%
8.48%
17.59%
EPS Growth (1Y)
-40.23%
-29.62%
-12.00%
-5.85%
-32.75%
-38.54%
-55.66%
-58.43%
-45.07%
-18.29%
10.10%
17.55%
Valuation Metrics
P/E TTM
-4.38
-1.46
-1.43
-1.01
-2.26
-4.61
-5.94
-5.14
-3.47
-3.41
-2.44
-1.72
P/B
15.33
-20.83
-32.88
36.34
8.25
9.48
9.35
6.31
-29.71
38.81
-107.01
-16.25
P/S TTM
1.46
0.58
0.71
0.54
1.23
2.78
3.97
3.76
2.98
3.62
3.51
2.73
Market Cap
140.01M
51.35M
56.63M
41.36M
91.25M
197.98M
260.41M
228.90M
163.47M
177.75M
154.73M
113.60M
Enterprise Value
160.84M
79.72M
87.04M
67.32M
110.25M
208.06M
265.03M
222.40M
187.40M
186.60M
159.75M
120.76M
Calculated Values
Free Cash Flow TTM
-25.10M
-23.53M
-29.16M
-31.13M
-45.01M
-51.88M
-62.21M
-60.99M
-45.97M
-45.79M
-44.40M
-45.83M
Net Debt
20.83M
28.37M
30.42M
25.97M
19.00M
10.08M
4.62M
-6.50M
23.93M
8.85M
5.02M
7.16M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2026-02-23Sale
Owner: Vazquez, Chris
Title: Chief Accounting Officer
Shares: 211
Price/Share: $12.78
Value: $2,696.58
Shares Owned: 1,586
Relationship: Officer
Ownership: Direct
2026-02-23Sale
Owner: Hutton, Scott
Title: President & CEO
Shares: 1,490
Price/Share: $12.78
Value: $19,042.20
Shares Owned: 48,767
Relationship: Director,Officer
Ownership: Direct
2026-02-23Sale
Owner: O'Kane, Kieran
Title: Chief Commercial Officer
Shares: 535
Price/Share: $12.78
Value: $6,837.30
Shares Owned: 9,819
Relationship: Officer
Ownership: Direct
2026-02-23Sale
Owner: Pestano, Gary Anthony
Title: Chief Development Officer
Shares: 556
Price/Share: $12.78
Value: $7,105.68
Shares Owned: 10,359
Relationship: Officer
Ownership: Direct
2026-02-23Sale
Owner: Cowie, Robin Harper
Title: CFO, Sec'y & Treasurer
Shares: 535
Price/Share: $12.78
Value: $6,837.30
Shares Owned: 16,231
Relationship: Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2026-03-31
36.87%
Inst. Shares: 3,560,629
Shares Outstanding: 9,656,000
2025-12-31
50.78%
Inst. Shares: 3,834,027
Shares Outstanding: 7,551,000
2025-09-30
43.83%
Inst. Shares: 3,287,202
Shares Outstanding: 7,500,000
2025-06-30
-
Inst. Shares: 104,046,261
Shares Outstanding: 7,332,800
2025-03-31
-
Inst. Shares: 159,778,365
Shares Outstanding: 7,300,000

Research Faster.
Invest Smarter.

BIODESIX INC (BDSX) financial data sourced directly from SEC EDGAR filings — including the latest 10-K annual report, 10-Q quarterly filings, insider transactions (SEC Form 4), institutional ownership (SEC Form 13F), Earning Marker Reaction Heat Map and 50+ calculated financial metrics like Price to Earnings Ratio (P/E), Return on Equity (ROE), Debt to Equity (D/E), Free Cash Flow Per Share (FCF/S), and Return on Invested Capital (ROIC). Unlike platforms that rely on third-party data aggregators, GeminIQ parses raw SEC filings directly — delivering institutional-grade accuracy at a fraction of the cost of Bloomberg Terminal or S&P Capital IQ.